Consultant/Researcher
Tanja Schmidt
Steno Diabetes Center Odense
Project management | ||
Project status | Open | |
Data collection dates | ||
Start | 01.04.2025 | |
End | 31.12.2026 | |
The aim is to reduce diabetes distress and improve psychological well-being and glycemic outcomes, in adults (18-35 years) with type 1 diabetes and moderate-to-severe diabetes distress. The intervention is a group-based psychological intervention (ACTnow), led by nurses, psychologists and physicians, and is designed in a format that can easily be integrated into future standard care. The intervention group will be compared with a waitlist control group, receiving the intervention after 3 months.
Objective This study aims to evaluate the effectiveness of a group-based psychological intervention in reducing diabetes distress among young adults (aged 18-35) with type 1 diabetes (T1D) and moderate to high levels of diabetes distress, using a randomized controlled trial (RCT) design. Background Diabetes distress refers to the emotional burden and concerns associated with managing diabetes. It negatively impacts quality of life, self-care behaviors, and glycemic control (HbA1c). An estimated 20-40% of individuals with T1D experience moderate to high diabetes distress, with the highest prevalence in young adults. A 2024 national Danish survey found that 38% of individuals aged 19-39 reported high diabetes distress. For young adults, distress is often linked to uncertainty about the future and frustration with complex treatment regimens. Although not classified as a psychiatric disorder, addressing the psychological impact of diabetes is crucial. Cognitive behavioral therapy (CBT)-based interventions tailored to diabetes have shown effectiveness in reducing distress, with group-based formats proving more beneficial than individual approaches. However, few studies have examined the impact of group-based interventions specifically for young adults with T1D, and evidence-based tools remain limited. Hypotheses Primary outcome: The intervention will significantly reduce diabetes distress. Secondary outcomes: Participants will show reduced concerns about diabetes technology, increased acceptance of diabetes-related thoughts and emotions, reduced anxiety and depression symptoms, and improved glycemic control (either increases or decreases in HbA1c depending on individual baseline levels).
18 - 35 year olds diagnosed with type 1 diabetes and moderate-to-severe diabetes distress (T1-DDS ≥ 2), treated in on of three diabetes outpatient clinics in the Region of Southern Denmark (Odense, Esbjerg, Sønderborg).
Blood samples (HbA1c levels) Questionnaire data (Demographics, diabetes distress, psychological well-being) Patient Journal (Diabetes technology, diabetes duration, complications, medicin, blood glucose profile - sensor data)
Department of Diabetes and Hormonal Diseases, Esbjerg and Grindsted Hospital
Department of Medical Diseases, Sønderborg Hospital
Steno Diabetes Center Copenhagen